128 related articles for article (PubMed ID: 23999299)
1. Putative dioxygen-binding sites and recognition of tigecycline and minocycline in the tetracycline-degrading monooxygenase TetX.
Volkers G; Damas JM; Palm GJ; Panjikar S; Soares CM; Hinrichs W
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1758-67. PubMed ID: 23999299
[TBL] [Abstract][Full Text] [Related]
2. Tigecycline is modified by the flavin-dependent monooxygenase TetX.
Moore IF; Hughes DW; Wright GD
Biochemistry; 2005 Sep; 44(35):11829-35. PubMed ID: 16128584
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for a new tetracycline resistance mechanism relying on the TetX monooxygenase.
Volkers G; Palm GJ; Weiss MS; Wright GD; Hinrichs W
FEBS Lett; 2011 Apr; 585(7):1061-6. PubMed ID: 21402075
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations.
Bartha NA; Sóki J; Urbán E; Nagy E
Int J Antimicrob Agents; 2011 Dec; 38(6):522-5. PubMed ID: 22014885
[TBL] [Abstract][Full Text] [Related]
5. Functional, biophysical, and structural bases for antibacterial activity of tigecycline.
Olson MW; Ruzin A; Feyfant E; Rush TS; O'Connell J; Bradford PA
Antimicrob Agents Chemother; 2006 Jun; 50(6):2156-66. PubMed ID: 16723578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA.
Bauer G; Berens C; Projan SJ; Hillen W
J Antimicrob Chemother; 2004 Apr; 53(4):592-9. PubMed ID: 14985271
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of 3-hydroxybenzoate hydroxylase from Comamonas testosteroni has a large tunnel for substrate and oxygen access to the active site.
Hiromoto T; Fujiwara S; Hosokawa K; Yamaguchi H
J Mol Biol; 2006 Dec; 364(5):878-96. PubMed ID: 17045293
[TBL] [Abstract][Full Text] [Related]
8. Transformation of tetracycline by TetX and its subsequent degradation in a heterologous host.
Ghosh S; LaPara TM; Sadowsky MJ
FEMS Microbiol Ecol; 2015 Jun; 91(6):. PubMed ID: 26038239
[TBL] [Abstract][Full Text] [Related]
9. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
Fluit AC; Florijn A; Verhoef J; Milatovic D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
[TBL] [Abstract][Full Text] [Related]
10. Structural and mechanistic basis of the high catalytic activity of monooxygenase Tet(X4) on tigecycline.
Cheng Q; Cheung Y; Liu C; Xiao Q; Sun B; Zhou J; Chan EWC; Zhang R; Chen S
BMC Biol; 2021 Dec; 19(1):262. PubMed ID: 34895224
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of an alternative mode of tigecycline binding to the bacterial ribosome.
Schedlbauer A; Kaminishi T; Ochoa-Lizarralde B; Dhimole N; Zhou S; López-Alonso JP; Connell SR; Fucini P
Antimicrob Agents Chemother; 2015 May; 59(5):2849-54. PubMed ID: 25753625
[TBL] [Abstract][Full Text] [Related]
12. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics.
Yang W; Moore IF; Koteva KP; Bareich DC; Hughes DW; Wright GD
J Biol Chem; 2004 Dec; 279(50):52346-52. PubMed ID: 15452119
[TBL] [Abstract][Full Text] [Related]
13. High Levels of Intrinsic Tetracycline Resistance in Mycobacterium abscessus Are Conferred by a Tetracycline-Modifying Monooxygenase.
Rudra P; Hurst-Hess K; Lappierre P; Ghosh P
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632012
[TBL] [Abstract][Full Text] [Related]
14. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).
Hirata T; Saito A; Nishino K; Tamura N; Yamaguchi A
Antimicrob Agents Chemother; 2004 Jun; 48(6):2179-84. PubMed ID: 15155219
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis.
Jenner L; Starosta AL; Terry DS; Mikolajka A; Filonava L; Yusupov M; Blanchard SC; Wilson DN; Yusupova G
Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3812-6. PubMed ID: 23431179
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
[TBL] [Abstract][Full Text] [Related]
17. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
Feng Z; Hou T; Li Y
Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
[TBL] [Abstract][Full Text] [Related]
18. Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
Fritsche TR; Strabala PA; Sader HS; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):209-13. PubMed ID: 16105566
[TBL] [Abstract][Full Text] [Related]
19. Using xenon as a probe for dioxygen-binding sites in copper amine oxidases.
Duff AP; Trambaiolo DM; Cohen AE; Ellis PJ; Juda GA; Shepard EM; Langley DB; Dooley DM; Freeman HC; Guss JM
J Mol Biol; 2004 Nov; 344(3):599-607. PubMed ID: 15533431
[TBL] [Abstract][Full Text] [Related]
20. Nonantibiotic properties of tetracyclines: structural basis for inhibition of secretory phospholipase A2.
Dalm D; Palm GJ; Aleksandrov A; Simonson T; Hinrichs W
J Mol Biol; 2010 Apr; 398(1):83-96. PubMed ID: 20211188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
